Testing a new insulin for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with type 2 diabetes for at least 6 months
- Currently taking basal insulin once or twice daily, or weekly insulin Icodec
- Age 18 or older
- Must use reliable birth control if there is any chance of pregnancy, and for 3 weeks after treatment ends
- No serious heart problems, like recent heart attack or heart failure, in the last 6 months
- No history of cancer in the past 5 years (except some easily treated skin cancers)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a new medicine called RZ-629. It looks at how safe it is, how the body processes it, and how it works in both healthy people and people with type 2 diabetes. If you have diabetes, you can join if your blood sugar is well controlled on your current pills.
This study checks whether two versions of an experimental medication (called GZR4) are the same in how they work in the body. It involves healthy adults and is a Phase 1 trial, meaning it's one of the first steps in testing a drug in humans.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This study tests an investigational medicine called GZR101-80 for people with type 2 diabetes. It aims to see how well it controls blood sugar and how safe it is.
This study tests a new injectable medication called GZR33 to help control blood sugar in people with type 2 diabetes who are already taking oral diabetes pills. The trial will measure how well it works and how safe it is.
This study compares a new investigational long-acting insulin (GZR33) to an approved one (insulin degludec) in people with type 1 diabetes. You would receive both insulins during an inpatient 'clamp' procedure to see how well they work, which may help find a more affordable or convenient option for daily blood sugar control.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.